Fosun, which holds a 57.86% stake in Gland Pharma, according to exchange data, did not immediately respond to Reuters' request for comment. Gland Pharma declined to comment.

(Reporting by Nandan Mandayam in Bengaluru; Editing by Savio D'Souza)